Table 2:

Prognostic ability of individual and combined miRs (Log2FC) to differentiate TACE responders from non-responders in serum samples collected from HCC patients

Groups	Predictor miR(s)	Cut-off value	Sensitivity	Specificity	AUC	SEM	p-value
			%	%
CR vs NR	miR-26a	0.807	100.00	100.00	1.000	0.000	<0.001
	miR-107	1.160	86.70	70.60	0.741	0.092	0.020
	miR-133	0.037	100.00	94.40	0.997	0.006	<0.001
	miR-26a & miR-133				1.000	0.000	<0.001
CR vs PR	miR-133	0.940	93.80	88.20	0.919	0.059	<0.001
	miR-26a & miR-133				0.934	0.057	<0.001
*(CR+PR) vs NR	miR-133	−1.600	97.00	83.30	0.965	0.028	<0.001
	miR-26a & miR-133				0.998	0.003	<0.001
PR vs NR	miR-26a	1.490	94.10	83.30	0.958	0.030	<0.001
	miR-106b	0.328	76.50	66.70	0.761	0.081	<0.001
	miR-133	−1.530	94.10	83.30	0.935	0.050	<0.001
	miR-26a & miR-133				0.997	0.005	<0.001

AUC=Area under ROC curve, CR=complete responders, PR=Partial responders, NR=non-responders to TACE.

^*Responders=CR+PR pooled together and compared to NR